日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis

阿巴西普与阿达木单抗在类风湿关节炎共享表位阳性和阴性患者中的疗效比较

Yap, Chuan Fu; Nair, Nisha; Sharma, Seema D; Bowes, John; Ariff, Amirah Binti Mohammad; Morgan, Ann W; Isaacs, John D; Wilson, Anthony G; Hyrich, Kimme L; Verstappen, Suzan; Bluett, James; Morris, Andrew P; Barton, Anne; Plant, Darren; Viatte, Sebastien

Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity score

基于双组分疾病活动度评分的类风湿关节炎炎症反应标准

Stadler, Michael; Rivellese, Felice; Plant, Darren; Nair, Nisha; Hyrich, Kimme L; Isaac, John; Morgan, Ann; Wilson, Anthony G; Verstappen, Suzanne M M; Lewis, Myles J; Bowes, John; Pitzalis, Costantino; Barton, Anne

Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDs

已确诊类风湿性关节炎患者开始接受生物制剂或靶向合成DMARD治疗时类固醇的使用模式

Stadler, Michael; Bindra, Shae; Cheung, Annie; Yap, Chuan Fu; Bluett, James; Plant, Darren; Nair, Nisha; Hyrich, Kimme; Morgan, Ann; Wilson, Anthony G; Isaacs, John D; Barton, Anne

Target Trial Emulation to Incorporate Real-World Data in the Estimation of the Clinical and Cost-Effectiveness of Biologic Treatment

目标试验模拟将真实世界数据纳入生物制剂治疗临床疗效和成本效益评估

Singh, Janharpreet; Stevenson, Matt; Hyrich, Kimme L; Gillies, Clare L; Abrams, Keith R; Bujkiewicz, Sylwia

Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole-Blood Transcriptomics Data

利用机器学习分析全血转录组学数据,识别接受阿达木单抗治疗的类风湿关节炎患者的疗效预测生物标志物

Yap, Chuan Fu; Nair, Nisha; Morgan, Ann W; Isaacs, John D; Wilson, Anthony G; Hyrich, Kimme; Barturen, Guillermo; Riva-Torrubia, María; Gut, Marta; Gut, Ivo; Alarcón Riquelme, Marta E; Barton, Anne; Plant, Darren

Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries

与生物制剂类疾病修饰抗风湿药相比,JAK抑制剂治疗类风湿关节炎患者发生主要不良心血管事件的风险:来自国际注册研究合作的数据

Aymon, Romain; Mongin, Denis; Guemara, Romain; Salis, Zubeyir; Askling, Johan; Choquette, Denis; Codreanu, Catalin; Di Giuseppe, Daniela; Flouri, Irini; Huschek, Doreen; Hyrich, Kimme L; Iannone, Florenzo; Kvien, Tore K; Leeb, Burkhard F; Nordström, Dan; Otero-Varela, Lucia; Pavelka, Karel; Pombo-Suarez, Manuel; Rodrigues, Ana; Rotar, Ziga; Sidiropoulos, Prodromos; Provan, Sella A; Strangfeld, Anja; Nina, Trokovic; Zavada, Jakub; Kearsley-Fleet, Lianne; Courvoisier, Delphine S; Finckh, Axel; Lauper, Kim

Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA

体重与托珠单抗治疗类风湿性关节炎疗效之间的关联:来自BSRBR-RA研究的结果

Tsoi, Man Fung; Kearsley-Fleet, Lianne; Azadbakht, Narges; Watson, Kath; Hyrich, Kimme L; Bluett, James

Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis

对于类风湿性关节炎患者,治疗前GlycA测量值除了常规临床测量外,没有提供额外的预测价值。

Ling, Stephanie F; Yap, Chuan Fu; Nair, Nisha; Verstappen, Suzanne M M; Morgan, Ann W; Isaacs, John D; Wilson, Anthony G; Hyrich, Kimme L; Barton, Anne; Plant, Darren

The incidence and prevalence of juvenile idiopathic arthritis differs between ethnic groups in England

在英国,不同种族群体中幼年特发性关节炎的发病率和患病率存在差异。

Beesley, Richard P; Hyrich, Kimme L; Humphreys, Jenny H

Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UK

欧洲药品管理局为最大限度降低JAK抑制剂严重副作用风险而采取的措施可能对英国JAK抑制剂的处方和使用产生影响

Tian, Zixing; Kearsley-Fleet, Lianne; Galloway, James; Watson, Kath; Lunt, Mark; Hyrich, Kimme L